In a study, peptidyl arginine deiminase 4 (PAD4) is identified as nasopharyngeal carcinoma (NPC) biomarker, negatively regulated by microRNA 3,164 (miR-3164). This evidence concerns the gene PADI4 and nasopharyngeal carcinoma.